Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma for hospitalized COVID-19 patients
IRCT20200525047562N1Phase 3Completed
- Sponsor
- High Institute for Research and Education in Transfusion Medicine
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 3, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by High Institute for Research and Education in Transfusion Medicine. Primary endpoints: Reduction in duration of hospital stay, Mortality reduction and 2 more. Started May 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200525047562N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200525047562N1.